SEC Form 4 · accession 0001387131-17-005770
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Dec 8, 2017
Accepted (ET)
Dec 11, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2017 | P | 5,000 | $6.21 | A | 679,500 | I | See Footnote |
| Common StockF2 | holding | — | — | — | 1,001 | I | See Footnote | |
| Common Stock | holding | — | — | — | 3,555 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Owned by Thompson Family Investments, LLC an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.
- F2Owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.